Ixempra Ixabepilone Injection In Mumbai

Ixempra (ixabepilone) is indicated as monotherapy for the treatment of metastatic or locally advanced breast cancer in patients whose tumors are resistant or refractory to anthracyclines, taxanes, and capecitabine. Ixempra is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment with an anthracycline and a taxane, or whose cancer is taxane resistant and for whom further anthracycline therapy is contraindicated. Anthracycline resistance is defined as progression while on therapy or within 6 months in the adjuvant setting or 3 months in the metastatic setting. Taxane resistance is defined as progression while on therapy or within 12 months in the adjuvant setting or 4 months in the metastatic setting.

With our in-depth knowledge and rich industry experience in this field, we are highly engaged in trading, exporting, wholesaling, distributing and supplying a qualitative Ixempra 45 Mg for our valuable clients. Used for breast cancer treatments, this injection is processed using the latest technology and excellent quality chemical compounds at vendors end. So as to ensure its quality, our experts strictly test this injection on diversified parameters. Features:Highly effective Long shelf life Balanced composition